CN103142987A - Medicament for treating mumps - Google Patents
Medicament for treating mumps Download PDFInfo
- Publication number
- CN103142987A CN103142987A CN2013101114471A CN201310111447A CN103142987A CN 103142987 A CN103142987 A CN 103142987A CN 2013101114471 A CN2013101114471 A CN 2013101114471A CN 201310111447 A CN201310111447 A CN 201310111447A CN 103142987 A CN103142987 A CN 103142987A
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- medicament
- rhizoma
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000003814 drug Substances 0.000 title claims abstract description 18
- 208000005647 Mumps Diseases 0.000 title claims abstract description 17
- 208000010805 mumps infectious disease Diseases 0.000 title claims abstract description 17
- 239000000463 material Substances 0.000 claims abstract description 7
- 244000268590 Euryale ferox Species 0.000 claims abstract description 4
- 235000006487 Euryale ferox Nutrition 0.000 claims abstract description 4
- 241000218378 Magnolia Species 0.000 claims abstract description 3
- 241000736026 Sarcandra Species 0.000 claims abstract description 3
- 241000628997 Flos Species 0.000 claims description 15
- 210000000582 semen Anatomy 0.000 claims description 10
- 241001164374 Calyx Species 0.000 claims description 5
- 244000064622 Physalis edulis Species 0.000 claims description 5
- 239000009670 cang er zi wan Substances 0.000 claims description 5
- 239000009609 fructus phyllanthi Substances 0.000 claims description 3
- 241000206501 Actaea <angiosperm> Species 0.000 claims description 2
- 240000007171 Imperata cylindrica Species 0.000 claims description 2
- 241000025505 Pyrrosia Species 0.000 claims description 2
- 241001530126 Scrophularia Species 0.000 claims description 2
- 239000002775 capsule Substances 0.000 claims description 2
- 239000007919 dispersible tablet Substances 0.000 claims description 2
- 239000003826 tablet Substances 0.000 claims description 2
- 230000000694 effects Effects 0.000 abstract description 3
- 235000013399 edible fruits Nutrition 0.000 abstract 3
- 240000004183 Bongardia chrysogonum Species 0.000 abstract 1
- 244000025254 Cannabis sativa Species 0.000 abstract 1
- 241001233914 Chelidonium majus Species 0.000 abstract 1
- 235000007516 Chrysanthemum Nutrition 0.000 abstract 1
- 244000189548 Chrysanthemum x morifolium Species 0.000 abstract 1
- 244000247747 Coptis groenlandica Species 0.000 abstract 1
- 235000002991 Coptis groenlandica Nutrition 0.000 abstract 1
- 240000006766 Cornus mas Species 0.000 abstract 1
- 244000119298 Emblica officinalis Species 0.000 abstract 1
- 235000015489 Emblica officinalis Nutrition 0.000 abstract 1
- 241000218671 Ephedra Species 0.000 abstract 1
- 241000735527 Eupatorium Species 0.000 abstract 1
- 235000014266 Geum aleppicum Nutrition 0.000 abstract 1
- 241000123870 Geum aleppicum Species 0.000 abstract 1
- 241000096284 Gynochthodes officinalis Species 0.000 abstract 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 abstract 1
- 235000000100 Hibiscus rosa sinensis Nutrition 0.000 abstract 1
- 241000208278 Hyoscyamus Species 0.000 abstract 1
- 241001598107 Imperata Species 0.000 abstract 1
- 241001465382 Physalis alkekengi Species 0.000 abstract 1
- 244000274050 Platycodon grandiflorum Species 0.000 abstract 1
- 235000006753 Platycodon grandiflorum Nutrition 0.000 abstract 1
- 241001571466 Potentilla discolor Species 0.000 abstract 1
- 241001116757 Pyrrosia lingua Species 0.000 abstract 1
- 241000681946 Rhododendron dauricum Species 0.000 abstract 1
- 235000000664 Rosa chinensis Nutrition 0.000 abstract 1
- 235000016785 Rosa della China Nutrition 0.000 abstract 1
- 235000000914 Solidago virgaurea Nutrition 0.000 abstract 1
- 244000067505 Xanthium strumarium Species 0.000 abstract 1
- 244000237330 gutta percha tree Species 0.000 abstract 1
- 239000000126 substance Substances 0.000 abstract 1
- 210000003681 parotid gland Anatomy 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 6
- 230000036760 body temperature Effects 0.000 description 5
- 230000008961 swelling Effects 0.000 description 4
- 208000015181 infectious disease Diseases 0.000 description 3
- 208000035473 Communicable disease Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 208000000112 Myalgia Diseases 0.000 description 2
- 210000000624 ear auricle Anatomy 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 239000000203 mixture Substances 0.000 description 2
- 241000711386 Mumps virus Species 0.000 description 1
- 206010034023 Parotid gland enlargement Diseases 0.000 description 1
- 206010034038 Parotitis Diseases 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 206010000496 acne Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000001055 chewing effect Effects 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000000762 glandular Effects 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 210000002216 heart Anatomy 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000000241 respiratory effect Effects 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 210000003296 saliva Anatomy 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 210000002700 urine Anatomy 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention discloses a medicament for treating mumps. The medicament is prepared from the following substances in parts by weight: 5-10 parts of radix scrophulariae, 10-20 parts of rhizoma zingiberis, 20-30 parts of dogwood, 10-20 parts of platycodon grandiflorum, 15-25 parts of goldthread, 5-15 parts of chrysanthemum, 10-30 parts of golden-rod, 1-15 parts of henbane, 10-20 parts of ephedra, 15-30 parts of pyrrosia lingua, 20-30 parts of magnolia flower, 1-20 parts of morinda officinalis, 1-20 parts of celandine, 10-25 parts of lalang grass rhizome, 10-30 parts of cocklebur fruit, 1-20 parts of emblic leafflower fruit, 15-20 parts of kamuning, 10-20 parts of eucommia ulmoides, 15-20 parts of herba inulae, 15-30 parts of herb of glabrous sarcandra, 10-20 parts of fructus aristolochiae, 10-25 parts of folium sennae, 5-15 parts of aleppo avens, 1-20 parts of uniflower swisscentaury root, 15-25 parts of rhododendron dauricum, 15-25 parts of potentilla discolor, 10-20 parts of chinese lantern-plant, 15-25 parts of rhizoma cimicifugae, 20-30 parts of lindley eupatorium, 1-20 parts of gorgon fruit and 10-25 parts of China rose. All components of the medicament for treating mumps disclosed by the invention are natural materials; and the medicament is good in security, definite in curative effect, and suitable for large-scale clinical popularization.
Description
Technical field
The present invention relates to field of medicaments, relate in particular to a kind of medicament for the treatment of mumps.
Background technology
Mumps is called for short the stream cheek, also claims mumps, is commonly called as " pig's head is crazy ", " mumps ", " to rumor " etc., is that spring is common, is also respiratory infectious disease common in child and teenager, also is found in the adult.It is to invade by mumps virus the acute respiration infectious disease that the parotid gland causes, and can invade the organs such as various glandular tissues or nervous system and liver, kidney, heart, joint, and patient is the source of infection, and the suction of the spittle is main route of transmission, 2-3 week morbidity after the contact patient.The parotitis main manifestations is enlargement under the ear-lobe of one or both sides, and the parotid gland of enlargement often is hemispherical, blur margin centered by ear-lobe, surface heat has angle pain, dehisce or when chewing the part feel pain.Searching for the medicament of new treatment mumps never stops.
Summary of the invention
The purpose of this invention is to provide a kind of medicament for the treatment of mumps.
in order to realize purpose of the present invention, the invention provides a kind of medicament for the treatment of mumps, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Rhizoma Coptidis 15-25 part, Flos Chrysanthemi 5-15 part, Herba Solidaginis 10-30 part, Semen Hyoscyami 1-15 part, Herba Ephedrae 10-20 part, Folium Pyrrosiae 15-30 part, Flos Magnoliae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Cortex Eucommiae 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Radix Achyranthis Bidentatae 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Rhizoma Cimicifugae 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Semen Euryales 1-20 part and Flos Rosae Chinensis 10-25 part.
preferably, the medicament for the treatment of mumps of the present invention is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of Rhizoma Coptidis, 13 parts of Flos Chrysanthemis, 28 parts of Herba Solidaginiss, 11 parts of Semen Hyoscyamis, 17 parts, Herba Ephedrae, 24 parts of Folium Pyrrosiaes, 27 parts of Flos Magnoliaes, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of the Cortexs Eucommiae, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Radix Achyranthis Bidentataes, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Rhizoma Cimicifugaes, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Semen Euryaless and Flos Rosae Chinensiss.
More preferably, described medicament can be tablet, dispersible tablet, capsule or decoction.
Whole compositions of the medicament for the treatment of mumps of the present invention are all natural materials, and safety is better, and curative effect is clear and definite, are suitable for large-scale promotion clinically.
The specific embodiment
Further illustrate the present invention below by embodiment.It should be understood that embodiments of the invention are for explanation the present invention rather than limitation of the present invention.Essence according to the present invention all belongs to the scope of protection of present invention to the simple modifications that the present invention carries out.Except as otherwise noted, otherwise the percent in the present invention is percetage by weight.
Embodiment decoction of the present invention
take Radix Scrophulariae 7 grams, Rhizoma Zingiberis 13 grams, Fructus Corni 22 grams, Radix Platycodonis 15 grams, Rhizoma Coptidis 21 grams, Flos Chrysanthemi 13 grams, Herba Solidaginis 28 grams, Semen Hyoscyami 11 grams, Herba Ephedrae 17 grams, Folium Pyrrosiae 24 grams, Flos Magnoliae 27 grams, Radix Morindae Officinalis 18 grams, Herba Chelidonii 17 grams, Rhizoma Imperatae 23 grams, Fructus Xanthii 21 grams, Fructus Phyllanthi 16 grams, Folium Et Cacumen Murrayae 16 grams, the Cortex Eucommiae 17 grams, Herba Inulae 19 grams, Herba Sarcandrae 15 grams, Herba Clinopodii 14 grams, Folium Sennae 21 grams, Radix seu Herba Gei aleppici 11 grams, Radix Rhapontici 13 grams, Radix Achyranthis Bidentatae 23 grams, Herba Potentillae Discoloris 24 grams, Calyx Seu Fructus Physalis 14 grams, Rhizoma Cimicifugae 25 grams, Herba Eupatorii Lindleyani 26 grams, Semen Euryales 16 grams and Flos Rosae Chinensis 24 grams, add 2000 milliliters of entry, in being housed, heated 4 hours under 80 ℃ by the flask of condensing tube, filter.Filtrate is concentrated into 600 milliliters, namely gets decoction of the present invention.
Experimental example
Diagnostic criteria
The national higher medical of reference academy teaching material " pediatrics mumps diagnostic criteria formulation (Wang Mudi, pediatrics [M] .5 version. Beijing: People's Health Publisher, 2002:201-202.): 1. epidemiology contact history, all can fall ill throughout the year, but common with early spring in winter evening.2. the body temperature moderate increases, headache, myalgia etc.3. the lower adenoncus of parotid gland enlargement or neck, tenderness.4. the accidental red pimple of trunk or urticaria.5. separablely from infant saliva, urine or blood go out parotid gland virus.
Choose 50 routine infants, male 25 examples, female's 25 examples; 2 months-5 years old age, 3.8 years old mean age.
Use the decoction for preparing in embodiment to treat, every day 2 times, each oral 50 milliliters.Treatment was 1 course for the treatment of in 3 days continuously.
The treatment standard is as follows
Cure: body temperature is down to normally, and headache, myalgia disappear, and parotid gland swelling and pain disappears.Produce effects: body temperature obviously descends, and parotid gland swelling and pain obviously alleviates.Effectively: body temperature descends to some extent, and parotid gland swelling and pain is alleviated.Invalid: body temperature continues to increase, and parotid gland swelling and pain is not alleviated or increased the weight of.
Therapeutic outcome
After treating 1 course for the treatment of, all infants all meet the standard of healing, and do not observe obvious untoward reaction.
Claims (3)
1. medicament for the treatment of mumps, it is characterized in that, it is to be made by the material of following weight proportioning: Radix Scrophulariae 5-10 part, Rhizoma Zingiberis 10-20 part, Fructus Corni 20-30 part, Radix Platycodonis 10-20 part, Rhizoma Coptidis 15-25 part, Flos Chrysanthemi 5-15 part, Herba Solidaginis 10-30 part, Semen Hyoscyami 1-15 part, Herba Ephedrae 10-20 part, Folium Pyrrosiae 15-30 part, Flos Magnoliae 20-30 part, Radix Morindae Officinalis 1-20 part, Herba Chelidonii 1-20 part, Rhizoma Imperatae 10-25 part, Fructus Xanthii 10-30 part, Fructus Phyllanthi 1-20 part, Folium Et Cacumen Murrayae 15-20 part, Cortex Eucommiae 10-20 part, Herba Inulae 15-20 part, Herba Sarcandrae 15-30 part, Herba Clinopodii 10-20 part, Folium Sennae 10-25 part, Radix seu Herba Gei aleppici 5-15 part, Radix Rhapontici 1-20 part, Radix Achyranthis Bidentatae 15-25 part, Herba Potentillae Discoloris 15-25 part, Calyx Seu Fructus Physalis 10-20 part, Rhizoma Cimicifugae 15-25 part, Herba Eupatorii Lindleyani 20-30 part, Semen Euryales 1-20 part and Flos Rosae Chinensis 10-25 part.
2. the medicament for the treatment of mumps according to claim 1, it is characterized in that, it is to be made by the material of following weight proportioning: 7 parts of Radix Scrophulariaes, 13 parts of Rhizoma Zingiberiss, 22 parts of Fructus Corni, 15 parts of Radix Platycodoniss, 21 parts of Rhizoma Coptidis, 13 parts of Flos Chrysanthemis, 28 parts of Herba Solidaginiss, 11 parts of Semen Hyoscyamis, 17 parts, Herba Ephedrae, 24 parts of Folium Pyrrosiaes, 27 parts of Flos Magnoliaes, 18 parts of Radix Morindae Officinaliss, 17 parts of Herba Chelidoniis, 23 parts of Rhizoma Imperataes, 21 parts of Fructus Xanthii, 16 parts of Fructus Phyllanthis, 16 parts of Folium Et Cacumen Murrayae, 17 parts of the Cortexs Eucommiae, 19 parts of Herba Inulae, 15 parts of Herba Sarcandraes, 14 parts of Herba Clinopodii, 21 parts of Folium Sennae, 11 parts of Radix seu Herba Gei aleppici, 13 parts of Radix Rhapontici, 23 parts of Radix Achyranthis Bidentataes, 24 parts of Herba Potentillae Discoloris, 14 parts of Calyx Seu Fructus Physaliss, 25 parts of Rhizoma Cimicifugaes, 26 parts of Herba Eupatorii Lindleyanis, 24 parts of 16 parts of Semen Euryaless and Flos Rosae Chinensiss.
3. the medicament for the treatment of mumps according to claim 1, is characterized in that, described medicament can be tablet, dispersible tablet, capsule or decoction.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310111447.1A CN103142987B (en) | 2013-03-22 | 2013-03-22 | Medicament for treating mumps |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310111447.1A CN103142987B (en) | 2013-03-22 | 2013-03-22 | Medicament for treating mumps |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103142987A true CN103142987A (en) | 2013-06-12 |
| CN103142987B CN103142987B (en) | 2014-02-05 |
Family
ID=48541497
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310111447.1A Expired - Fee Related CN103142987B (en) | 2013-03-22 | 2013-03-22 | Medicament for treating mumps |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103142987B (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103893601A (en) * | 2014-04-17 | 2014-07-02 | 李俊瑶 | Medicament for treating epidemic parotitis |
| CN104352640A (en) * | 2014-11-22 | 2015-02-18 | 邹士东 | Pharmaceutical composition for treating parotitis |
| CN105748574A (en) * | 2016-05-17 | 2016-07-13 | 李晓维 | Traditional Chinese medicine for treating angina parotidea |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102058720A (en) * | 2010-12-24 | 2011-05-18 | 郑国静 | Chinese medical cataplasm for treating epidemic mumps |
-
2013
- 2013-03-22 CN CN201310111447.1A patent/CN103142987B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN102058720A (en) * | 2010-12-24 | 2011-05-18 | 郑国静 | Chinese medical cataplasm for treating epidemic mumps |
Non-Patent Citations (1)
| Title |
|---|
| 陈吉兵: "中西医综合治疗流行性腮腺炎临床体会", 《中国社区医师·医学专业》 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103893601A (en) * | 2014-04-17 | 2014-07-02 | 李俊瑶 | Medicament for treating epidemic parotitis |
| CN104352640A (en) * | 2014-11-22 | 2015-02-18 | 邹士东 | Pharmaceutical composition for treating parotitis |
| CN105748574A (en) * | 2016-05-17 | 2016-07-13 | 李晓维 | Traditional Chinese medicine for treating angina parotidea |
Also Published As
| Publication number | Publication date |
|---|---|
| CN103142987B (en) | 2014-02-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102319294A (en) | Double-vanilla preparation and preparation method thereof | |
| CN103142987B (en) | Medicament for treating mumps | |
| CN102139051B (en) | Application of soft capsule capable of clearing heat and eliminating toxin in preparation of medicament for treating viral pneumonia | |
| CN103142982A (en) | Medicine for treating acute upper respiratory infection | |
| CN116139237B (en) | A Chinese medicinal composition for preventing and treating respiratory tract infection caused by coronavirus, and its application | |
| CN101249255B (en) | Proprietary Chinese medicine for curing children's cough and method of preparing the same | |
| CN1326552C (en) | Medicine for treating viral influenza, and its prepn. method | |
| CN101507743A (en) | Biennial wormwood extract and preparation method thereof | |
| CN103142981A (en) | Medicament for treating mammitis | |
| CN101683429A (en) | Animal Chinese medicine granular formulation for preventing and treating infectious bursal disease of fowl and preparation method thereof | |
| CN102488802B (en) | Medicament for treating epidemic parotitis | |
| CN103191385B (en) | Medicament for treating infantile asthma | |
| CN103142974B (en) | Medicament for treating anxiety disorder | |
| CN103142983B (en) | Medicament for treating chronic pharyngitis | |
| CN104524256A (en) | Traditional Chinese medicine for treating viral pneumonia | |
| CN102793869A (en) | Traditional Chinese medicine composition for controlling porcine viral diseases and preparation method thereof | |
| CN102727589B (en) | Medicament for treating cough with lung heat of children | |
| CN106310219A (en) | Compound oral solution with pholcodine | |
| CN105250774A (en) | Traditional Chinese medicine composition for treating chronic influenza | |
| CN101112546A (en) | Chinese traditional medicine composition for treating and preventing fowl virosis and method for preparing the same | |
| CN101049346A (en) | Medication for treating rhinitis and tympanitis, and preparation method | |
| CN101259165A (en) | Chaihuang preparations and producing method thereof | |
| CN105362888A (en) | Medicine for treating allergic rhinitis | |
| CN103142973B (en) | Medicament for treating neurasthenia | |
| CN108339020A (en) | A kind of preparation method of three forks hardship injection |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: HU RONG Free format text: FORMER OWNER: YANG JUAN Effective date: 20131231 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent of invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Hu Rong Inventor before: Yang Juan |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 272501 JINING, SHANDONG PROVINCE TO: 272025 JINING, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: YANG JUAN TO: HU RONG |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20131231 Address after: Supply road 272025 in Shandong province Jining City District No. 12 Jining Maternal and Child Health-Care Hospital of Pediatrics Applicant after: Hu Rong Address before: 272501 Shandong province Dehui Wenshang County Road No. 2 Applicant before: Yang Juan |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140205 Termination date: 20160322 |